Long-Term Follow-Up Results of Adjuvant Intensity-Modulated Radiotherapy with Concurrent Paclitaxel and Cisplatin in High-Risk Endometrial Cancer Patients

Table 2

Characteristics of patients ().

Variables	No. of patients (%)
Age (years), median (range)	55 (27-81)
FIGO 2009 stage
Stage IA	9 (4)
Stage IB	33 (14.3)
Stage II	97 (42)
Stage IIIa	33 (14.3)
Stage IIIb	12 (5.2)
Stage IIIc	43 (18.6)
Stage IV	4 (1.7)
Histological grade and type
EEC grade 1	43 (18.6)
EEC grade 2	73 (31.6)
EEC grade3	83 (35.9)
Serous	5 (2.2)
Adenosquamous cell carcinoma	25 (10.8)
Clear cell carcinoma	1 (0.4)
Neuroendocrine carcinoma	1 (0.4)
Myometrial invasion
<50%	63 (27.3)
>50%	82 (35.5)
Missing	86 (37.2)
LVSI
Yes	179 (77.5)
No	5 (2.2)
Unknown	47 (20.3)
Lymphode positive	39 (16.9)
Parametrium invasion	9 (3.9)

FIGO: International Federation of Obstetrics and Gynecology; EEC: endometrial endometrioid cancer; LVSI: lymph-vascular space invasion.